| Genomewide profiling of copy‐number alteration in monoclonal gammopathy of undetermined significance A Mikulasova, J Smetana, M Wayhelova, H Janyskova, V Sandecka, ... European journal of haematology 97 (6), 568-575, 2016 | 33 | 2016 |
| CD20 is dispensable for B-cell receptor signaling but is required for proper actin polymerization, adhesion and migration of malignant B cells V Kozlova, A Ledererova, A Ladungova, H Peschelova, P Janovska, ... Plos one 15 (3), e0229170, 2020 | 21 | 2020 |
| Hypermethylation of CD19 promoter enables antigen-negative escape to CART-19 in vivo and in vitro A Ledererova, L Dostalova, V Kozlova, H Peschelova, A Ladungova, ... Journal for Immunotherapy of Cancer 9 (8), 2021 | 18 | 2021 |
| Performance of anti-CD19 chimeric antigen receptor T cells in genetically defined classes of chronic lymphocytic leukemia V Mancikova, H Peschelova, V Kozlova, A Ledererova, A Ladungova, ... Journal for ImmunoTherapy of Cancer 8 (1), 2020 | 12 | 2020 |
| Lyn phosphorylates and controls ROR1 surface dynamics during chemotaxis of CLL cells Z Dave, O Vondálová Blanářová, Š Čada, P Janovská, N Zezula, M Běhal, ... Frontiers in Cell and Developmental Biology 10, 838871, 2022 | 6 | 2022 |
| Identification of a family with SUFU germline deletion based on a case of desmoplastic medulloblastoma in an infant J Šoukalová, K Vejmělková, T Cermanová, K Kašíková, A Mikulášová, ... Klinicka Onkologie: Casopis Ceske a Slovenske Onkologicke Spolecnosti 29, S83-8, 2016 | 5 | 2016 |
| Whole genome amplification effect on segmental copy-number changes and copy-number neutral loss of heterozygosity analysis by oligonucleotide-based array-comparative genomic … A Mikulasova, J Smetana, M Wayhelová, H Janyskova, S Okubote, ... International Journal of Clinical and Experimental Pathology 9 (7), 6965-6976, 2016 | 1 | 2016 |
| Exploring the Mechanisms of Venetoclax Resistance Via Drug Screening and Genome-Wide CRISPR Screening A Ladungova, H Peschelova, L Dostalova, Y Lodhi, NV Gottumukkala, ... Blood 142, 5759, 2023 | | 2023 |
| Genome-wide CRISPR/Cas9 knockout screening revealed genes involved in CD20 regulation in rituximab-resistant cells. L Dostálová, A Ledererová, H Peschelová, T Loja, M Šmída | | 2023 |
| Identification of novel targets that upregulate CD20 expression in rituximab-resistant cells with the use of genomewide CRISPR screening. L Dostálová, A Ledererová, H Peschelová, T Loja, M Šmída | | 2023 |
| CRISPR/Cas9 knockout screening revealed genes involved in CD20 regulation. L Dostálová, A Ledererová, H Peschelová, V Hejret, M Šmída | | 2022 |
| Genome-wide Screening Optimizations and High-throughput Compound Screening to Identify Novel Treatment Options in Venetoclax-resistant AML Y Lodhi, A Ladungová, D Buša, H Peschelová, M Čulen, M Šmída | | 2022 |
| Prediction of novel treatment options for CLL and AML cells based on drug repurposing. A Ladungová, D Buša, H Peschelová, Y Lodhi, M Čulen, M Šmída | | 2022 |
| CD19 promoter hypermethylation as means of antigen-negative escape to CART-19 therapy. L Dostálová, A Ledererová, V Kozlová, H Peschelová, A Ladungová, ... | | 2021 |
| Drug repositioning in genetically defined CLL cases reveals a potentional novel therapeutic use for approved drugs. A Ladungová, H Peschelová, V Kozlová, M Šmída | | 2021 |
| In vivo antigen-negative escape to CART-19 caused by CD19 promotor hypermethylation. L Dostálová, A Ledererová, V Kozlová, H Peschelová, A Ladungová, ... | | 2021 |
| Lyn controls chemotaxis and motility of CLL cells via phosphorylation of ROR1 Z Dave, OV Blanářová, Š Čada, P Janovská, N Zezula, M Běhal, ... bioRxiv, 2020.05. 29.124156, 2020 | | 2020 |
| CRISPR/CAS9 technology: a useful tool in the study of chronic lymphocytic leukemia H Peschelová, V Kozlová, V Mančíková, A Ladungová, V Hejret, M Šmída | | 2020 |
| Impact of genetics on the performance of anti-CD 19 chimeric antigen receptor T cells in chronic lymphocytic leukemia V Mančíková, V Kozlová, H Peschelová, J Mayer, Š Pospíšilová, M Šmída | | 2020 |
| Genome-wide CRISPR/Cas9 screening reveals novel target genes, whose inactivation is able to upregulate surface expression of immunotherapy target CD20 H Peschelová, L Dostálová, V Kozlová, A Ledererová, V Hejret, M Šmída | | 2020 |
